| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $3,460,119 ) |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM156859 | Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional Settings | 000 | 1 | NIH | 4/18/2025 | $278,104 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AG086447 | Mechanisms of CD8+ mediated cell non-autonomous arterial aging | 000 | 2 | NIH | 12/24/2024 | $535,902 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R16GM146705 | Using Cognitive Offloading to Mitigate Age-Related Declines in Prospective Memory | 000 | 3 | NIH | 12/5/2024 | $38,271 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R25EB032766 | Enhancing Undergraduate Bioengineering Education through Engaged Service Learning, Clinical Immersion, and Entrepreneurship | 000 | 4 | NIH | 4/4/2025 | $41,600 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 000 | 4 | NIH | 4/25/2025 | $470,519 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM155429 | Understanding what regulates a regulator: the molecular basis for homeostatic small RNA-mediated gene regulation | 000 | 2 | NIH | 5/13/2025 | $373,397 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM142489 | In Vivo Genetic Analysis of Compartmentalized Cell Elimination | 000 | 4 | NIH | 1/20/2025 | $30,960 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15CA290638 | High-throughput Identification and Validation of Drugs to Target Migrating and Treatment-Resistant Glioblastoma Cells | 000 | 1 | NIH | 1/21/2025 | $451,996 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AG075582 | Mapping Trajectories of Alzheimer's Progression via Personalized Brain Anchor-nodes | 000 | 4 | NIH | 1/13/2025 | $488,633 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01DE031872 | Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach | 000 | 3 | NIH | 3/4/2025 | $409,138 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 001 | 7 | NIH | 1/27/2025 | $334,643 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | K23MD016431 | Genomic signatures of inflammation: Pathways of racial discrimination, depressive symptoms, Vitamin D status with preterm birth among Black women | 001 | 4 | NIH | 11/27/2024 | $102,265 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | F31AI169954 | A nanocoating for continuous disinfection of frequently touched surfaces | 000 | 2 | NIH | 1/14/2025 | -$7,056 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01EB033913 | A Novel Spray-On Sensing Platform Technology that Enables Wearable Visual Monitoring of Physiological Data and Environmental Exposure | 000 | 2 | NIH | 4/25/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM116031 | Catalytic Reductive C-H and C-C Silylation with Silyl Acetals | 001 | 3 | NIH | 10/23/2024 | $1,219 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 001 | 2 | NIH | 3/31/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 000 | 2 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 003 | 6 | NIH | 2/14/2025 | $402 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 000 | 6 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | UR650344 | Maternal Health Research Network (MH-RN) for MSIs--Research Awards | 01 | 2 | HRSA | 3/6/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | K23MD016431 | Genomic signatures of inflammation: Pathways of racial discrimination, depressive symptoms, Vitamin D status with preterm birth among Black women | 003 | 4 | NIH | 4/11/2025 | $14,553 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R34AA028730 | Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | 005 | 4 | NIH | 3/7/2025 | $176 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R34AA028730 | Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | 003 | 4 | NIH | 10/31/2024 | -$18 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R34AA028730 | Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | 001 | 4 | NIH | 10/25/2024 | $142,628 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R25LM014215 | Training and Experiential Learning in Biomedical Informatics (TExBioMed) | 000 | 2 | NIH | 4/23/2025 | -$42,992 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01MD017596 | Complex Systems Approaches to Advance Maternal Health Disparities Research and Prevention: Developing a System Dynamics Simulation Model of Severe Maternal Morbidity among Black Women | 000 | 1 | NIH | 11/29/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AI168159 | Mechanistic basis of how LD-transpeptidases protect against outer membranedefects | 000 | 2 | NIH | 12/20/2024 | -$138,722 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM143053 | Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii | 001 | 3 | NIH | 12/18/2024 | -$1 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HD097330 | Bioactive adhesive material for early vaginal wall detachment in pelvic organ prolapse | 000 | 5 | NIH | 12/5/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01NS105621 | Preserving Mitochondrial Function for Alleviating ALS Progression | 000 | 5 | NIH | 3/21/2025 | $0 |
| | 2025 | 2022 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM143053 | Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii | 000 | 2 | NIH | 12/18/2024 | -$49,375 |
| | 2025 | 2022 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01GM132481 | Multiscale Modeling of Protein Kinase Structure, Catalysis and Allostery | 000 | 4 | NIH | 4/8/2025 | -$5,023 |
| | 2025 | 2022 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 002 | 5 | NIH | 2/14/2025 | -$402 |
| | 2025 | 2022 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S Nedderman Dr., Box 19145 | Arlington | TX | 76019-0145 | TARRANT | USA | R4245812 | R42 MCH Secondary Data Analysis Research | 04 | 1 | HRSA | 4/25/2025 | -$94 |
| | 2025 | 2021 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15EB030842 | Combining Experiments and Computer Simulation to Improve the Stem Cell Differentiation Process | 000 | 1 | NIH | 2/5/2025 | $0 |
| | 2025 | 2021 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21CA240220 | IMAT-ITCR Collaboration - Identification and development of T cell receptor mimic antibodies for high value neoantigen targets in triple negative breast cancer | 000 | 1 | NIH | 12/3/2024 | -$1,830 |
| | 2025 | 2021 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15EB030809 | Mapping activeness of very small tumors in breast for patient stratification | 000 | 1 | NIH | 4/16/2025 | $0 |
| | 2025 | 2020 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM116031 | Catalytic Reductive C-H and C-C Silylation with Silyl Acetals | 000 | 2 | NIH | 10/23/2024 | -$1,219 |
| | 2025 | 2020 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15HL150708 | Attenuation correction strategies for myocardial perfusion imaging using dual-gated SPECT | 000 | 1 | NIH | 12/17/2024 | -$7,555 |
|
| Issue Date FY: 2024 ( Subtotal = $9,538,825 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21HL167171 | Retrospective Single Image Multi-endPoint anaLysis (SIMPL) to define pathophysiologic mechanisms of heart failure with preserved ejection fraction. | 000 | 2 | NIH | 8/24/2024 | $122,220 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM155429 | Understanding what regulates a regulator: the molecular basis for homeostatic small RNA-mediated gene regulation | 000 | 1 | NIH | 7/23/2024 | $374,188 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01MD017596 | Complex Systems Approaches to Advance Maternal Health Disparities Research and Prevention: Developing a System Dynamics Simulation Model of Severe Maternal Morbidity among Black Women | 000 | 2 | NIH | 7/31/2024 | $362,166 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R16GM146705 | Using Cognitive Offloading to Mitigate Age-Related Declines in Prospective Memory | 000 | 3 | NIH | 8/7/2024 | $192,500 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21GM148895 | EnzyDock-based Multistate and Multiscale Tools for Covalent Drug Design | 001 | 2 | NIH | 6/18/2024 | $16,201 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21GM148895 | EnzyDock-based Multistate and Multiscale Tools for Covalent Drug Design | 000 | 2 | NIH | 11/28/2023 | $145,808 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01EB033913 | A Novel Spray-On Sensing Platform Technology that Enables Wearable Visual Monitoring of Physiological Data and Environmental Exposure | 000 | 2 | NIH | 5/21/2024 | $256,876 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 000 | 3 | NIH | 5/2/2024 | $470,519 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 001 | 3 | NIH | 5/3/2024 | $59,904 |
|
